Immediate surgery compared with short-course neoadjuvant gemcitabine plus capecitabine, FOLFIRINOX, or chemoradiotherapy in patients with borderline resectable pancreatic cancer (ESPAC5): a four-arm, multicentre, randomised, phase 2 trial

Publication | Open Access

DOI Full Paper Access

294

Citations

References

2022

Year

Paula Ghaneh, Daniel H. Palmer, Silvia Cicconi, Richard Jackson, Christopher Halloran, Charlotte Rawcliffe, Rajaram Sripadam, Somnath Mukherjee, Zahir Soonawalla, Jonathan Wadsley,

The Lancet. Gastroenterology & hepatology

Surgical OncologyImmediate SurgeryPancreatic CancerGastrointestinal OncologyMedicineShort-course Neoadjuvant GemcitabinePancreatic SurgerySurgeryOncologyRadiation Oncology